United States: 4 Areas Of Heightened Antitrust Risk In Private Equity - Sheppard Mullin Richter & Hampton

Mondaq

29 May 2023 0 shares 1 views

United States: 4 Areas Of Heightened Antitrust Risk In Private Equity - Sheppard Mullin Richter & Hampton

Mondaq

Published 29 May 2023

Antitrust enforcers are echoing claims of recent books and articles decrying private equity firms' reshaping of American business in ways allegedly antithetical to competition.

Full Article

United States: New Notice And Public Disclosure Requirements For Material Health Care Transactions In New York - Sheppard Mullin Richter & Hampton

Mondaq 22 May 2023

The growth of private equity and other financial sponsor investments in the health care industry has led many states across the..

More coverage

United States: Withdrawal Of Drug Approval Highlights Risk Of Accelerated Approval Pathway - Sheppard Mullin Richter & Hampton

On April 5, 2023, the U.S. Food and Drug Administration ("FDA") announced its decision to withdraw the approval of Makena®..

Mondaq 10 May 2023

United States: 4 Areas Of Heightened Antitrust Risk In Private Equity - Sheppard Mullin Richter & Hampton

United States: 4 Areas Of Heightened Antitrust Risk In Private Equity - Sheppard Mullin Richter & Hampton

You might like

Related news coverage

United States: New Notice And Public Disclosure Requirements For Material Health Care Transactions In New York - Sheppard Mullin Richter & Hampton

Advertisement

More coverage

United States: Withdrawal Of Drug Approval Highlights Risk Of Accelerated Approval Pathway - Sheppard Mullin Richter & Hampton